Angela Lorts, MD

Director, Ventricular Assist Device Program

Associate Professor, UC Department of Pediatrics

Phone 513-803-1675

Fax 513-636-3952

Email angela.lorts@cchmc.org

Clinical Interests

Heart failure; cardiopulmonary bypass mediated myocardial dysfunction

Research Interests

Myocardial remodeling

MD: Creighton University Medical School, Omaha, Nebraska, 1998.

Residency: The Children’s Hospital, Denver, Colorado, 2001.

Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, 2004. University of Michigan Medical Center, Ann Arbor, Michigan, 2006.

Certifications: American Board of Pediatrics, 2001; American Board of Pediatrics, Sub-Board of Pediatric Cardiology, 2004; American Board of Pediatrics, Sub-Board of Pediatric Critical Care, 2006.

Lorts A, Burroughs T, Shanley TP. Elucidating the role of reversible protein phosphorylation in sepsis-induced myocardial dysfunction. Shock. 2009 Jul;32(1):49-54. Review.

Lorts A, Schwanekamp JA, Elrod JW, Sargent MA, Molkentin JD. Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell cycle activity, or cardiac repair. Circ Res. 2009 Jan 2;104(1):e1-7.

Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, Sargent MA, Lorts A, Brunskill EW, Dorn GW 2nd, Conway SJ, Aronow BJ, Robbins J, Molkentin JD. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res. 2007 Aug 3;101(3):313-21.

McLean KM, Lorts A, Pearl JM. Current treatments for congenital aortic stenosis. Curr Opin Cardiol. 2006 May;21(3):200-4. Review.